| 1 |
Hydrodynamically balanced tablets of clarithromycin: An approach to prolong and increase the local action by gastric retention |
|
|
| Sutar, R., Masareddy, R., Roopesh, K. |
|
| Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2010; 1(3): 284-295 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori Targeted nanoparticles for the treatment of H. pylori |
|
|
| Ramteke, S., Ganesh, N., Bhattacharya, S., Jain, N.K. |
|
| Journal of Drug Targeting. 2009; 17(3): 225-234 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori |
|
|
| Ramteke, S., Ganesh, N., Bhattacharya, S., Jain, N. |
|
| Journal of Drug Targeting. 2008; 16(9): 694-705 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Helicobacter pylori eradication prevents recurrence after simple closure of perforated duodenal ulcer |
|
|
| Bose, A.C., Kate, V., Ananthakrishnan, N., Parija, S.C. |
|
| Journal of Gastroenterology and Hepatology. 2007; 22(3): 345-348 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi |
|
|
| Lwai-Lume, L., Ogutu, E.O., Amayo, E.O., Kariuki, S. |
|
| East African Medical Journal. 2005; 82(12): 603-608 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Studies on gangliosides with affinity for Helicobacter plyori: Binding to natural and chemically modified structures |
|
|
| Miller-Podraza, H., Johansson, P., Ånström, J., Larsson, T., Longard, M., Karlsson, K.-A. |
|
| Glycobiology. 2004; 14(3): 205-217 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Bismuthine BiH3: Fact or fiction? High-resolution infrared, millimeter-wave, and Ab initio studies |
|
|
| Zoellner, R.W. |
|
| Chemtracts. 2002; 15(12): 637-641 |
|
| [Pubmed] [Google Scholar] |
|
